Literature DB >> 8063659

Endothelin receptor subtypes in human versus rabbit pulmonary arteries.

T Fukuroda1, M Kobayashi, S Ozaki, M Yano, T Miyauchi, M Onizuka, Y Sugishita, K Goto, M Nishikibe.   

Abstract

We studied which endothelin (ET) receptor subtypes mediate ET-1-induced vasocontraction in the human pulmonary artery (PA) compared with the rabbit PA. ET-1 produced potent contraction in both human and rabbit isolated PAs. In human PA, ET-1-induced contraction was competitively antagonized by BQ-123 (an ETA receptor antagonist) with a pA2 value of 7.68. In rabbit PA, however, even a high concentration of BQ-123 (1 microM) did not affect the contraction. BQ-3020 (an ETB receptor agonist) produced potent contraction in rabbit PA but not in human PA. Binding assays of the membrane preparations showed that human and rabbit PAs contained ETA and ETB receptors in ratios of 93:7 and 23:77, respectively. These results suggest interspecies differences in the ET receptor subtypes that mediate ET-1-induced vasocontraction; ETA receptors are dominant in the human PA, whereas ETB receptors are dominant in the rabbit PA. Furthermore, the predominance of ETA receptors in human PA was supported by autoradiographical studies. If ET-1 acts as a physiological and/or pathophysiological vasocontractor in the human pulmonary circulation, an ETA receptor antagonist would function as a pulmonary vasodilator in humans.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8063659     DOI: 10.1152/jappl.1994.76.5.1976

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  27 in total

1.  ET(A) receptors are the primary mediators of myofilament calcium sensitization induced by ET-1 in rat pulmonary artery smooth muscle: a tyrosine kinase independent pathway.

Authors:  A M Evans; H J Cobban; G F Nixon
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Effect of ABT-627 (A-147627), a potent selective ET(A) receptor antagonist, on the cardiopulmonary profile of newborn lambs with surgically-induced diaphragmatic hernia.

Authors:  M Kavanagh; B Battistini; S Jean; J Crochetière; L Fournier; J Wessale; T J Opgenorth; R Cloutier; D Major
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

Review 3.  Pulmonary hypertension with left-sided heart disease.

Authors:  Marco Guazzi; Ross Arena
Journal:  Nat Rev Cardiol       Date:  2010-10-05       Impact factor: 32.419

4.  EndothelinB receptor-mediated contraction in human pulmonary resistance arteries.

Authors:  K M McCulloch; C C Docherty; I Morecroft; M R MacLean
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

5.  Regional differences in the density and subtype specificity of endothelin receptors in rabbit urinary tract.

Authors:  J Latifpour; Y Fukumoto; R M Weiss
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-11       Impact factor: 3.000

Review 6.  Models and Molecular Mechanisms of World Health Organization Group 2 to 4 Pulmonary Hypertension.

Authors:  Ping Yu Xiong; Francois Potus; Winnie Chan; Stephen L Archer
Journal:  Hypertension       Date:  2017-11-20       Impact factor: 10.190

7.  ETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro.

Authors:  J J Maguire; A P Davenport
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

8.  Comparison of endothelin B (ETB) receptors in rabbit isolated pulmonary artery and bronchus.

Authors:  D W Hay; M A Luttmann; G Beck; E H Ohlstein
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

9.  The role of endothelin-1 as a mediator of the pressure response after air embolism in blood perfused lungs.

Authors:  J Schmeck; T Koch; B Patt; A Heller; H Neuhof; K van Ackern
Journal:  Intensive Care Med       Date:  1998-06       Impact factor: 17.440

Review 10.  Lung Circulation.

Authors:  Karthik Suresh; Larissa A Shimoda
Journal:  Compr Physiol       Date:  2016-03-15       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.